Cargando…
Addressing the Barriers to Clinical Trials Accrual in Community Cancer Centres Using a National Clinical Trials Navigator:A Cross-Sectional Analysis
INTRODUCTION: Clinical trials, although academically accepted as the most effective treatment available for cancer patients, poor accrual to clinical trials remains a significant problem. A clinical trials navigator (CTN) program was piloted where patients and/or their healthcare professionals could...
Autores principales: | Hamm, Caroline, Cavallo-Medved, Dora, Moudgil, Devinder, McGrath, Lee, Huang, John, Li, Yueyang, Stratton, Tyler W., Robinson, Tyler, Naccarato, Krista, Sundquist, Stephen, Dancey, Janet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520135/ https://www.ncbi.nlm.nih.gov/pubmed/36165718 http://dx.doi.org/10.1177/10732748221130164 |
Ejemplares similares
-
Clinical Trial Accrual: Obstacles and Opportunities
por: Rimel, B. J.
Publicado: (2016) -
Accrual monitoring in cardiovascular trials
por: Baldi, Ileana, et al.
Publicado: (2017) -
Participation in Cancer Clinical Trials: Researching the Causes of Low Accrual
por: Hallquist Viale, Pamela
Publicado: (2016) -
Accrual and retention of diverse patients in psychosocial cancer clinical trials
por: Hanvey, Grace Ann, et al.
Publicado: (2022) -
Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network
por: Visweswaran, Shyam, et al.
Publicado: (2018)